Source Date | Board Meeting Date | Details |
08-May-2025
|
22-May-2025
|
Quarterly Results & Audited Results
|
14-Jan-2025
|
06-Feb-2025
|
Quarterly Results
|
25-Oct-2024
|
13-Nov-2024
|
Quarterly Results
|
23-Sep-2024
|
30-Sep-2024
|
Inter alia, to consider and approve:- (1) integration and consolidation of the generics formulations business in the US market.
|
26-Jul-2024
|
08-Aug-2024
|
Quarterly Results
|
09-May-2024
|
22-May-2024
|
Audited Results
|
15-Jan-2024
|
05-Feb-2024
|
Quarterly Results
|
18-Oct-2023
|
01-Nov-2023
|
Quarterly Results
|
05-Jul-2023
|
14-Jul-2023
|
Quarterly Results
|
15-May-2023
|
23-May-2023
|
Audited Results
|
27-Jan-2023
|
06-Feb-2023
|
Quarterly Results
|
03-Nov-2022
|
11-Nov-2022
|
Quarterly Results
|
01-Aug-2022
|
09-Aug-2022
|
Quarterly Results
|
19-May-2022
|
27-May-2022
|
Final Dividend & Audited Results
|
21-Jan-2022
|
29-Jan-2022
|
Quarterly Results
|
25-Oct-2021
|
02-Nov-2021
|
Quarterly Results
|
23-Jul-2021
|
31-Jul-2021
|
Quarterly Results
|
21-May-2021
|
29-May-2021
|
Final Dividend & Audited Results
|
22-Jan-2021
|
30-Jan-2021
|
Quarterly Results
|
23-Oct-2020
|
31-Oct-2020
|
Quarterly Results
|